Trademarkia Logo

United Kingdom

£
Trademark Search
LYELL

View On IPO.GOV.UK

Registered

on 4 Apr 2023

Last Applicant/ Owned by

Lyell Immunopharma, Inc.

201 Haskins Way, South San Francisco

California, , 94080

Serial Number

UK00003896926 filed on 4th Apr 2023

Registration Number

UK00003896926 registered on
11th Aug 2023

Correspondent Information

Lane IP Limited

The Forum, St Paul's, 33 Gutter Lane

London,

EC2V 8AS

LYELL

pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; cells for medical or clinical purpos Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes .

Class [40]
Treatment & Processing of Materials Services

Custom manufacture of pharmaceuticals.

Class [42]
Computer & Software Services & Scientific Services

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research; scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of cancer.

Class [44]
Medical, Beauty & Agricultural Services

Medical services; medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer.

Mark Details

Serial Number

UK00003896926

Mark Type

Figurative

Kind of mark

Individual